AADI - Aadi Bioscience, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
15,216
15,216
1,000
14,000
Cost of revenue
1,335
1,335
-
-
Gross profit
13,881
13,881
-
-
Operating expenses
Research development
32,662
32,662
19,670
15,008
Selling general and administrative
40,176
40,176
18,511
2,121
Total operating expenses
72,838
72,838
38,061
16,549
Operating income or loss
-58,957
-58,957
-37,061
-2,549
Interest expense
230
230
665
815
Total other income/expenses net
-3,724
-3,724
-72,375
-153
Income before tax
-60,513
-60,513
-110,088
-3,476
Income tax expense
0
0
2
2
Income from continuing operations
-60,513
-60,513
-110,090
-3,478
Net income
-60,513
-60,513
-110,090
-3,478
Net income available to common shareholders
-60,513
-60,513
-110,737
-4,465
Basic EPS
-
-2.69
-12.41
-0.21
Diluted EPS
-
-2.69
-12.41
-0.21
Basic average shares
-
22,511
8,923
20,838
Diluted average shares
-
22,511
8,923
20,838
EBITDA
-
-60,283
-109,423
-2,652